Clinical Trial Update: Initial Versus Delayed PDT Combination With Conbercept in PCV [Phase 4]

View source ↗

Summary

Phase 4 trial comparing initial versus delayed photodynamic therapy (PDT) in combination with conbercept for polypoidal choroidal vasculopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: The Eye Hospital of Wenzhou Medical University | Conditions: Polypoidal Choroidal Vasculopathy | Phase 4 | Status: COMPLETED